A detailed history of Advocate Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Advocate Group LLC holds 77,294 shares of ABBV stock, worth $13.9 Million. This represents 2.77% of its overall portfolio holdings.

Number of Shares
77,294
Previous 76,999 0.38%
Holding current value
$13.9 Million
Previous $13.2 Million 15.58%
% of portfolio
2.77%
Previous 2.66%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$163.84 - $199.33 $48,332 - $58,802
295 Added 0.38%
77,294 $15.3 Million
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $61,451 - $71,761
-397 Reduced 0.51%
76,999 $13.2 Million
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $130,413 - $148,593
-816 Reduced 1.04%
77,396 $14.1 Million
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $139,113 - $156,674
-1,011 Reduced 1.28%
78,212 $12.1 Million
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $121,299 - $140,422
908 Added 1.16%
79,223 $11.8 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $406,938 - $506,407
3,071 Added 4.08%
78,315 $10.6 Million
Q1 2023

Apr 19, 2023

SELL
$144.61 - $166.54 $434,842 - $500,785
-3,007 Reduced 3.84%
75,244 $12 Million
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $300,962 - $360,933
-2,176 Reduced 2.71%
78,251 $0
Q3 2022

Oct 19, 2022

SELL
$134.21 - $153.93 $494,832 - $567,539
-3,687 Reduced 4.38%
80,427 $10.8 Million
Q2 2022

Jul 27, 2022

BUY
$137.62 - $174.96 $11.6 Million - $14.7 Million
84,114 New
84,114 $12.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Advocate Group LLC Portfolio

Follow Advocate Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advocate Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advocate Group LLC with notifications on news.